de Gasparo M - Search Results

1

Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.

Davis BJ, Cao Z, de Gasparo M, Kawachi H, Cooper ME, Allen TJ. Davis BJ, et al. Among authors: de gasparo m. J Hypertens. 2003 Jan;21(1):209-16. doi: 10.1097/00004872-200301000-00031. J Hypertens. 2003. PMID: 12544453

2

Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury.

Cao Z, Bonnet F, Candido R, Nesteroff SP, Burns WC, Kawachi H, Shimizu F, Carey RM, De Gasparo M, Cooper ME. Cao Z, et al. Among authors: de gasparo m. J Am Soc Nephrol. 2002 Jul;13(7):1773-87. doi: 10.1097/01.asn.0000019409.17099.33. J Am Soc Nephrol. 2002. PMID: 12089373

3

Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition?

Cooper ME, Webb RL, de Gasparo M. Cooper ME, et al. Among authors: de gasparo m. Cardiovasc Drug Rev. 2001 Spring;19(1):75-86. doi: 10.1111/j.1527-3466.2001.tb00184.x. Cardiovasc Drug Rev. 2001. PMID: 11314602 Review.

4

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

Watson AM, Li J, Schumacher C, de Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KA. Watson AM, et al. Among authors: de gasparo m. Diabetologia. 2010 Jan;53(1):192-203. doi: 10.1007/s00125-009-1540-3. Epub 2009 Oct 28. Diabetologia. 2010. PMID: 19862499

5

Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats.

Webb RL, Navarrete AE, Davis S, de Gasparo M. Webb RL, et al. Among authors: de gasparo m. J Hypertens. 1998 Jun;16(6):843-52. doi: 10.1097/00004872-199816060-00016. J Hypertens. 1998. PMID: 9663925

6

Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.

Siragy HM, El-Kersh MA, De Gasparo M, Webb RL, Carey RM. Siragy HM, et al. Among authors: de gasparo m. J Hypertens. 2002 Jun;20(6):1157-63. doi: 10.1097/00004872-200206000-00028. J Hypertens. 2002. PMID: 12023686

7

Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.

Siragy HM, de Gasparo M, Carey RM. Siragy HM, et al. Among authors: de gasparo m. Hypertension. 2000 May;35(5):1074-7. doi: 10.1161/01.hyp.35.5.1074. Hypertension. 2000. PMID: 10818067

8

AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits.

de las Heras N, Aragoncillo P, Maeso R, Vazquez-Pérez S, Navarro-Cid J, DeGasparo M, Mann J, Ruilope LM, Cachofeiro V, Lahera V. de las Heras N, et al. Hypertension. 1999 Oct;34(4 Pt 2):969-75. doi: 10.1161/01.hyp.34.4.969. Hypertension. 1999. PMID: 10523393

9

Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage.

Gelosa P, Pignieri A, Fändriks L, de Gasparo M, Hallberg A, Banfi C, Castiglioni L, Turolo L, Guerrini U, Tremoli E, Sironi L. Gelosa P, et al. Among authors: de gasparo m. J Hypertens. 2009 Dec;27(12):2444-51. doi: 10.1097/HJH.0b013e3283311ba1. J Hypertens. 2009. PMID: 19680135

10

Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet.

Labat C, Lacolley P, Lajemi M, de Gasparo M, Safar ME, Benetos A. Labat C, et al. Among authors: de gasparo m. Hypertension. 2001 Sep;38(3):439-43. doi: 10.1161/01.hyp.38.3.439. Hypertension. 2001. PMID: 11566919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters